Keyword: DAIICHI SANKYO

News

AstraZeneca and Daiichi Sankyo in Cancer Drug Deal

06.08.2020 -

UK-Swedish drugmaker AstraZeneca has entered into a global development and commercialization agreement with Daiichi Sankyo, which could be worth up to $6 billion for the...

News

AstraZeneca in $6.9 Billion Rights Share Deal

03.04.2019 - In a move to accelerate the development of its oncology franchise, AstraZeneca has agreed a $6.9 billion deal with Japanese pharma major Daiichi Sankyo to share rights to a new...

News

AstraZeneca Sells Gastro Treatment to Swiss Group Tillotts

13.07.2015 - In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...

News

Daiichi Sankyo Unloads Entire Stake in Sun Pharma

23.04.2015 - In a pre-negotiated share sale agreed a year ago, Japan's Daiichi Sankyo has unloaded its entire 8.9% stake in India's mammoth generics producer Sun Pharmaceutical Industries...

News

India’s Sun Pharmaceutical to Buy Compatriot Ranbaxy

09.04.2014 - Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...

News

Daiichi Sankyo Pledges “Bold Action” on Ranbaxy Ban

04.02.2014 - Japan's Daiichi Sankyo said it would send personnel to help resolve problems at a production facility of its drugmaking subsidiary Ranbaxy at Toansa in India's northern state of...

Plant Construction & Process Technology

Saltigo: 'Working Proactively With Trends'

11.09.2013 - Adaptability — A lot has happened in the world of custom manufacturing since Saltigo was carved out of Lanxess' fine chemicals business in 2006. Companies these days look to their...

News

Saltigo to Provide Contract Manufacturing Services for Daiichi Sankyo

08.07.2013 - Saltigo has signed an agreement with Tokyo-based Daiichi Sankyo for the provision of contract manufacturing services; this comes ahead of Daiichi Sankyo's plans to commercialize...